Allovate, LLC – Trademark Portfolio
Entity Type: 16
Allovate, LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ALLOVATE. The owner is based in New York, NY.
Suite 1
20 West 125th Street
New York, NY 10027
Showing of trademarks Trademarks
Trademark Classifications
Allovate, LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does Allovate, LLC have?
Allovate, LLC has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned, 1 cancelled.
What trademark classes does Allovate, LLC file in?
Allovate, LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Allovate, LLC's most well-known trademarks?
Allovate, LLC's registered trademark portfolio includes well-known marks such as ALLOVATE. These are among 1 currently registered trademark in the portfolio.
What is Allovate, LLC's trademark registration success rate?
Allovate, LLC has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.